A disruptive technology allowing fast protein sequencing and is both complementary and challenging to mass spectrometry. The technology doesn’t just allow the determination of a protein sequence much more quickly but also is starting to show the potential to become the gold standard for protein variant analysis where mass spectrometry currently struggles. The products incorporate instrumentation and proprietary consumables.
The vision is that this technology will be a key technology in every Omics / proteomics lab in the world and will require multiple systems at each site. Currently they are seeding the early adopter /Key opinion leader market and it is your job to develop these first key sites with a view to capitalizing on the early main stream market in the next 1 to 3 yrs.
Ideally the company is looking for someone with commercial Omics market exposure who has shown the ability to develop and build a market in the DACH region.
The opportunities for personal development in this role are potentially very high as this company is likely to be a major player in what is a very well funded and key market area and you would be a key player in the initial and rapidly expanding European team.
